Lycia Therapeutics
Lycia Therapeutics is the operator of a biotechnology firm that aims to research and produce first-in-class therapies. The company's lysosomal targeting chimeras (LYTACs) platform is used to develop therapeutics that degrade extracellular and membrane-bound proteins that drive a variety of difficult-to-treat diseases, such as cancer and autoimmune conditions, allowing doctors to obtain drugs to cure patients.
Domain
lyciatx.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$106.6M
Founded
2018
Tech Stack (21 technologies)
Frequently Asked Questions
What technologies does Lycia Therapeutics use?+
Lycia Therapeutics uses 21 technologies including jsDelivr, Modernizr, WordPress.
What industry is Lycia Therapeutics in?+
Lycia Therapeutics operates in the Biotechnology industry.
Where is Lycia Therapeutics based?+
Lycia Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026